دورية أكاديمية
Unmet needs and barriers in venous thromboembolism education and awareness among people living with cancer: a global survey.
| العنوان: | Unmet needs and barriers in venous thromboembolism education and awareness among people living with cancer: a global survey. |
|---|---|
| المؤلفون: | Potere N; Department of Medicine and Ageing Sciences, School of Medicine and Health Sciences, 'G. D'Annunzio' University, Chieti, Italy. Electronic address: nic.potere@gmail.com., Mahé I; Innovative Therapies in Haemostasis, INSERM UMR_S1140, INNOVTE-FRIN Université Paris Cité, Assistance Publique des Hôpitaux de Paris, Hôpital Louis Mourier, Paris, France., Angchaisuksiri P; Division of Hematology, Department of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand., Cesarman-Maus G; Department of Hematology, Instituto Nacional de Cancerología, Mexico City, Mexico., Tan CW; Department of Hematology, Royal Adelaide Hospital, University of Adelaide, Adelaide, South Australia, Australia., Rashid A; Section of Haematology, Department of Pathology & Laboratory Medicine/Oncology, Aga Khan University Hospital, Karachi, Pakistan., AlGahtani FH; Division of Hematology-Oncology, Oncology Center, Department of Medicine, King Saud University, Riyadh, Saudi Arabia., Imbalzano E; Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy., van Es N; Department of Vascular Medicine, Amsterdam UMC - University of Amsterdam, Amsterdam, The Netherlands; Amsterdam Cardiovascular Sciences, Pulmonary Hypertension and Thrombosis, Amsterdam, The Netherlands., Leader A; Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Petah Tikva; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Department of Medicine, Hematology Service, Memorial Sloan Kettering Cancer Center, New York City, New York, USA., Olayemi E; Department of Hematology, University of Ghana Medical School, Accra, Ghana., Porreca E; Department of Innovative Technologies in Medicine and Dentistry, School of Medicine and Health Sciences, 'G. D'Annunzio' University, Chieti, Italy., Ní Áinle F; Department of Hematology, Mater Misericordiae University Hospital and Rotunda Hospital, Dublin, Ireland; School of Medicine, University College, Dublin, Ireland., Okoye HC; Department of Hematology and Immunology, College of Medicine, University of Nigeria, Enugu, Nigeria., Candeloro M; Department of Innovative Technologies in Medicine and Dentistry, School of Medicine and Health Sciences, 'G. D'Annunzio' University, Chieti, Italy., Mayeur D; Medical Oncology, Transversal Department of Supportive Care, Association Francophone des Soins Oncologiques de Support, Centre Georges-François Leclerc, Dijon, France., Valerio L; Centers for Thrombosis and Hemostasis and Cardiology, University Hospital Mainz, Mainz, Germany., Clark RC; Programs and Education, International Society on Thrombosis and Haemostasis, Carrboro, North Carolina, USA., Castellucci LA; Department of Medicine, Ottawa Hospital Research Institute and University of Ottawa, Ottawa, Ontario, Canada., Barco S; Centers for Thrombosis and Hemostasis and Cardiology, University Hospital Mainz, Mainz, Germany; Department of Angiology, University Hospital Zurich, Zurich, Switzerland., Di Nisio M; Department of Medicine and Ageing Sciences, School of Medicine and Health Sciences, 'G. D'Annunzio' University, Chieti, Italy. |
| مؤلفون مشاركون: | World Thrombosis Day Steering Committee and Collaborators |
| المصدر: | Journal of thrombosis and haemostasis : JTH [J Thromb Haemost] 2024 Jul; Vol. 22 (7), pp. 1973-1983. Date of Electronic Publication: 2024 Apr 04. |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: Elsevier Country of Publication: England NLM ID: 101170508 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-7836 (Electronic) Linking ISSN: 15387836 NLM ISO Abbreviation: J Thromb Haemost Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: 2023- : [New York] : Elsevier Original Publication: Oxford : Blackwell Pub. |
| مواضيع طبية MeSH: | Venous Thromboembolism*/etiology , Neoplasms*/psychology , Neoplasms*/complications , Health Knowledge, Attitudes, Practice* , Patient Education as Topic* , Awareness*, Humans ; Cross-Sectional Studies ; Male ; Female ; Middle Aged ; Adult ; Aged ; Risk Factors ; Needs Assessment ; Health Services Needs and Demand ; Surveys and Questionnaires ; Global Health |
| مستخلص: | Background: Venous thromboembolism (VTE) is a major preventable cause of morbidity, disability, and mortality in subjects with cancer. A global appraisal of cancer-associated VTE education and awareness is not available. Objectives: To evaluate VTE-related education, awareness, and unmet needs from the perspective of people living with cancer using a quantitative and qualitative approach. Methods: This cross-sectional study used data from an online-based survey covering multidimensional domains of cancer-associated VTE. Data are presented descriptively. Potential differences across participant subgroups were explored. Results: Among 2262 patients with cancer from 42 countries worldwide, 55.3% received no VTE education throughout their cancer journey, and an additional 8.2% received education at the time of VTE diagnosis only, leading to 63.5% receiving no or inappropriately delayed education. When education was delivered, only 67.8% received instructions to seek medical attention in case of VTE suspicion, and 36.9% reported scarce understanding. One-third of participants (32.4%) felt psychologically distressed when becoming aware of the potential risks and implications connected with cancer-associated VTE. Most responders (78.8%) deemed VTE awareness highly relevant, but almost half expressed concerns about the quality of education received. While overall consistent, findings in selected survey domains appeared to numerically differ across age group, ethnicity, continent of residence, educational level, metastatic status, and VTE history. Conclusion: This study involving a large and diverse population of individuals living with cancer identifies important unmet needs in VTE-related education, awareness, and support across healthcare systems globally. These findings unveil multilevel opportunities to expedite patient-centered care in cancer-associated VTE prevention and management. Competing Interests: Declaration of competing interests N.P. reports a training fellowship from the International Society on Thrombosis and Haemostasis and research funding from International Network of VENous Thromboembolism Clinical Research Networks (INVENT) outside of the submitted work. I.M. reports research funding from Leo Pharma and BMS-Pfizer outside of the submitted work, and advisory board/honoraria from Bayer, BMS-Pfizer, Leo, and Sanofi. P.A. reports research funding from Novo Nordisk, Sanofi, and Spark Therapeutics outside of the submitted work. G.C.M. reports personal fees from Bayer and BMS-Pfizer outside the submitted work. N.V.E. received, outside of the submitted work, advisory board honoraria from Daiichi-Sankyo, Bayer, and Leo Pharma paid to his institution. A.L. reports lecture fees from Leo Pharma outside the submitted work. E.O. reports funding from Novo Nordisk outside the submitted work and Pfizer advisory board/honoraria. F.N.A. reports grant funding (IIS paid to university) from Daiichi-Sankyo, Leo Pharma, Sanofi, and Actelion, and consultancy for Boston Scientific, outside of the submitted work. H.C.O. received a training fellowship from the International Society on Thrombosis and Haemostasis. D.M. reports speaker fees from Leo Pharma, BMS, and Pfizer. C.A. reports personal fees from Bayer, BMS/Pfizer, Daiichi-Sankyo, and Sanofi outside the submitted work. L.A.C. reports that her research institution has received honoraria from Bayer, BMS-Pfizer Alliance, The Academy for Continued Advancement in Healthcare Education, Amag Pharmaceutical, Leo Pharma, Sanofi, Valeo Pharma, and Servier. S.B. received consultancy and speaker fees from Bayer, Concept Medical, Boston Scientific, and Inari outside of the submitted work. M.D.N. reports personal fees from Bayer, Daiichi-Sankyo, BMS-Pfizer, Leo Pharma, and Viatris outside the submitted work. The remaining authors report no relevant conflicts of interest to disclose. (Copyright © 2024 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.) |
| فهرسة مساهمة: | Keywords: access; and evaluation; healthcare quality; neoplasms; patient preference; surveys and questionnaires; value-based healthcare; venous thromboembolism |
| تواريخ الأحداث: | Date Created: 20240406 Date Completed: 20240630 Latest Revision: 20240630 |
| رمز التحديث: | 20240701 |
| DOI: | 10.1016/j.jtha.2024.03.019 |
| PMID: | 38582384 |
| قاعدة البيانات: | MEDLINE |
| تدمد: | 1538-7836 |
|---|---|
| DOI: | 10.1016/j.jtha.2024.03.019 |